KeyOps operates a trusted, compliant digital platform that breaks down communication barriers between life science companies and healthcare providers to enable faster, real-time decision making for medical affairs, marketing and sales teams. The platform lets customers build and manage on-demand relationships with a diverse community of key opinion leaders and medical experts. KeyOps positions itself as a digital-first alternative to traditional, time-consuming physician engagement methods by delivering fast, accurate data from a trusted provider network. The company says its product removes friction from physician engagement and supports strategic decision making for pharmaceutical commercial teams. KeyOps will use new growth funding to invest in product development and to expand into the U.S. market. The company was founded in 2020 and is based in Toronto. KeyOps operates a trusted, compliant digital platform that connects doctors and other key opinion leaders (KOLs) with life‑science companies to speed commercial decision‑making and improve responses to patient needs. The platform is positioned for medical affairs, marketing, and sales teams to build and manage on‑demand relationships with a diverse community of medical experts. KeyOps currently serves device manufacturers, laboratory testing companies, and pharmaceutical customers across multiple therapeutic areas. The company plans to use its seed funding to add engineering, product development, and sales and marketing roles over the next year, with a focus on building a U.S. commercial team. It also intends to grow its physician network across North America to broaden expert coverage. KeyOps is Toronto‑based and raised capital in December 2022 to support this expansion.

Total raised

$3M

Funding rounds

2

Latest round

Seed

Latest activity

Dec 2022